HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exogenous supplementation of Activin A enhances germ cell differentiation of human embryonic stem cells.

Abstract
Human embryonic stem cells (hESCs) derived in the presence of Activin A (ActA) demonstrate an increased differentiation propensity toward the germ cell lineage. In addition, mouse epiblast stem cells and mouse epiblast-like cells are poised toward germ cell differentiation and are derived in the presence of ActA. We therefore investigated whether supplementation with ActA enhances in vitro hESC differentiation toward germ cell lineage. ActA up-regulated early primordial germ cell (PGC) genes STELLA/DPPA3 (developmental pluripotency associated 3) and tyrosine kinase receptor cKIT in both ActA-derived and standard-derived hESCs indicating its role in priming hESCs toward the PGC lineage. Indeed, ActA plus bone morphogenic protein 4 (BMP4) strongly increased germ cell differentiation potential of hESCs based on the high expression of late PGC markers DAZL (deleted in azoospermia-like) and VASA/DDX4 (DEAD-box polypeptide 4) at mRNA and protein level. Hence, the combination of ActA with BMP4 provides an additional boost for hESCs to develop into postmigratory germ cells. Together with increased VASA expression in the presence of ActA and BMP4, we also observed up-regulation of endoderm-specific genes GATA4 (GATA binding protein 4) and GATA6. Finally, we were able to further mature these in vitro-derived PGC-like cells (PGCLCs) by culturing them in in vitro maturation (IVM) medium, resulting in the formation of germ cell-like clusters and induction of meiotic gene expression. In conclusion, we demonstrate for the first time a synergism between ActA and BMP4 in facilitating germ cell-directed differentiation of hESCs, which is enhanced by extended culture in IVM medium, as shown by cytoplasmic VASA-expressing PGCLCs. We propose a novel relationship between the endoderm and germ cell lineage during hESC differentiation.
AuthorsGalbha Duggal, Björn Heindryckx, Sharat Warrier, Jasin Taelman, Margot Van der Jeught, Dieter Deforce, Susana Chuva de Sousa Lopes, Petra De Sutter
JournalMolecular human reproduction (Mol Hum Reprod) Vol. 21 Issue 5 Pg. 410-23 (May 2015) ISSN: 1460-2407 [Electronic] England
PMID25634576 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • BMP4 protein, human
  • Biomarkers
  • Bone Morphogenetic Protein 4
  • Chromosomal Proteins, Non-Histone
  • DAZL protein, human
  • DPPA3 protein, human
  • GATA4 Transcription Factor
  • GATA4 protein, human
  • GATA6 Transcription Factor
  • GATA6 protein, human
  • Proteins
  • RNA-Binding Proteins
  • activin A
  • Activins
  • Proto-Oncogene Proteins c-kit
  • DDX4 protein, human
  • DEAD-box RNA Helicases
Topics
  • Activins (metabolism)
  • Belgium
  • Biomarkers (metabolism)
  • Bone Morphogenetic Protein 4 (metabolism)
  • Cell Differentiation
  • Cell Line
  • Cell Lineage
  • Cells, Cultured
  • Chromosomal Proteins, Non-Histone
  • DEAD-box RNA Helicases (genetics, metabolism)
  • Embryoid Bodies (cytology, metabolism)
  • GATA4 Transcription Factor (genetics, metabolism)
  • GATA6 Transcription Factor (genetics, metabolism)
  • Gene Expression Regulation, Developmental
  • Germ Cells (cytology, metabolism)
  • Human Embryonic Stem Cells (cytology, metabolism)
  • Humans
  • Proteins (genetics, metabolism)
  • Proto-Oncogene Proteins c-kit (genetics, metabolism)
  • RNA-Binding Proteins (genetics, metabolism)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: